EL7.AI
StocksMediumUpdated×2•Originally published 7 May 2026•Updated 8 May 2026•
1 min read

BDX, SHOO, and BRKR Shares Rally Following Strong Q1 Earnings Beats

Key Facts

1Becton, Dickinson and Company (BDX) beat second-quarter fiscal 2026 earnings and revenue estimates.
2Steven Madden (SHOO) shares rose 6% after raising its fiscal year 2026 revenue outlook.
3Bruker (BRKR) exceeded Q1 earnings and revenue estimates driven by strong growth in Europe.

Shares of BDX, SHOO, and BRKR climbed following quarterly results that surpassed estimates, with BDX reporting Q2 revenue of $4.7 billion. Although BDX posted an EPS loss of $0.13, the results were impacted by a significant $1.6 billion one-off loss and a $274 million loss from discontinued operations. Meanwhile, Steven Madden shares surged 6% after upwardly revising its 2026 revenue guidance, and Bruker reported strong results fueled by robust growth in European operations. Madrigal Pharmaceuticals (MDGL) also maintained its momentum, supported by robust sales of Rezdiffra amid growing demand for MASH treatments. This performance across the healthcare and consumer sectors reflects organic growth momentum despite specific accounting headwinds. The combination of raised forward guidance and resilient revenue figures continues to generate optimism in the market.